EUVIMEDEUVIMED entdecken
Crossref

Therapeutic strategies in severe neuropsychiatric systemic lupus erythematosus: experience from a tertiary referral centre

A Bortoluzzi, M Padovan, I Farina, E Galuppi, F De Leonardis, M Govoni

Reumatismo · 31.12.2012 · 64 (6)

DOI: 10.4081/reumatismo.2012.350 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Reumatismo, online erschienen am 31.12.2012. Verfasst von A Bortoluzzi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Unità Operativa Complessa e Sezione di Reumatologia, Dipartimento di Medicina Clinica e Sperimentale, Università di Ferrara e Azienda Ospedaliero-Uni…. Die Arbeit wurde bisher 17-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

UNLABELLED: The management of neuropsychiatric systemic lupus erythematosus (NPSLE) still remains empirical and based on clinical experience due to the lack of randomized controlled trials. OBJECTIVE: To report the experience accumulated in a single tertiary referral centre about treatment of severe cases of NPSLE patients and to discuss therapeutic strategies on the background of EULAR recommendations. METHODS: Retrospective analysis of all consecutive cases of severe NPSLE treated in our centre since 1990 to 2010, satisfying the 1999 ACR criteria. RESULTS: Among 633 SLE patients who consecutively attended our centre, 231 (36%) displayed at least one neuropsychiatric (NP) manifestation for a total of 408 events attributable to SLE. Thirty-one patients (4.8%), 27 females and 4 males, experienced 35 major NP events requiring immunosuppressive therapy (including 3 relapses and 1 new event). An aggressive immunosuppressive strategy was applied to those patients with an immune mediated inflammatory NP event and to those patients with an increased disease activity as judged by ECLAM and SLEDAI scores. Overall at the end of the therapy 74% of the patients reached clinical remission or significant improvement of their symptoms measured by mean SLEDAI (from 10.09 ± 1.09 to 2.04 ± 0.52, P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdultAgedAutoantibodiesBrainComorbidityDisease ManagementDrug Therapy, CombinationFemaleHELLP SyndromeHumansImmunosuppressive AgentsItalyLupus Erythematosus, SystemicMagnetic Resonance ImagingMaleMental DisordersMiddle AgedNervous System DiseasesPregnancyPrevalence

Substanzen

AutoantibodiesImmunosuppressive Agents

Autor:innen und Institutionen

  • Unità Operativa Complessa e Sezione di Reumatologia, Dipartimento di Medicina Clinica e Sperimentale, Università di Ferrara e Azienda Ospedaliero-Universitaria S. Anna, Ferrara, Italy. alessandra_bortoluzzi@virgilio.it

Zitieren

APA

Bortoluzzi, A., Padovan, M., Farina, I., Galuppi, E., De Leonardis, F., & Govoni, M. (2012). Therapeutic strategies in severe neuropsychiatric systemic lupus erythematosus: experience from a tertiary referral centre. Reumatismo, 64(6). https://doi.org/10.4081/reumatismo.2012.350

Vancouver

Bortoluzzi A, Padovan M, Farina I, Galuppi E, De Leonardis F, Govoni M. Therapeutic strategies in severe neuropsychiatric systemic lupus erythematosus: experience from a tertiary referral centre. Reumatismo. 2012;64(6). doi:10.4081/reumatismo.2012.350

BibTeX
@article{Bortoluzzi2012,
  author = {Bortoluzzi, A and Padovan, M and Farina, I and Galuppi, E and De Leonardis, F and Govoni, M},
  title = {Therapeutic strategies in severe neuropsychiatric systemic lupus erythematosus: experience from a tertiary referral centre},
  journal = {Reumatismo},
  year = {2012},
  volume = {64},
  number = {6},
  doi = {10.4081/reumatismo.2012.350}
}
Kostenlos starten →